Does cetirizine (Zyrtec) have any drug‑drug interactions with apixaban (Eliquis), flecainide, losartan, or carvedilol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Clinically Significant Drug Interactions Between Zyrtec and Your Medications

Cetirizine (Zyrtec) does not have clinically significant drug-drug interactions with apixaban (Eliquis), flecainide, losartan, or carvedilol, and can be safely used concurrently with these medications.

Evidence-Based Analysis

Apixaban (Eliquis)

The FDA label for apixaban explicitly states that it is metabolized primarily via CYP3A4 and P-glycoprotein (P-gp) 1. Cetirizine is not a CYP3A4 inhibitor or inducer, nor is it a significant P-gp inhibitor. The FDA label lists specific drugs requiring dose adjustments (combined P-gp and strong CYP3A4 inhibitors like ketoconazole, itraconazole, ritonavir) 1, and cetirizine is notably absent from these warnings.

While one case report described a pharmacokinetic interaction between cetirizine and pilsicainide (a different antiarrhythmic) via renal transporters in a patient with renal insufficiency 2, this involved competition for renal excretion—a mechanism not relevant to apixaban's metabolism or your other medications.

Flecainide

Flecainide is primarily renally excreted and metabolized by CYP2D6 3. The single case report of cetirizine-pilsicainide interaction 2 involved renal transporter competition (MRP1 and OCT2), but this was in a patient with severe renal insufficiency taking supratherapeutic doses of cetirizine (20 mg/day vs. standard 10 mg/day). In patients with normal renal function taking standard cetirizine doses, no clinically meaningful interaction with flecainide is expected.

Losartan and Carvedilol

Neither losartan nor carvedilol have documented interactions with cetirizine. The ACC/AHA hypertension and heart failure guidelines 4, 5, 6, 7 do not list antihistamines as interacting medications with ARBs or beta-blockers. These guidelines extensively detail drug interactions for these cardiovascular medications, and cetirizine is not mentioned.

Important Safety Considerations

Cetirizine's Cardiac Safety Profile

Cetirizine is considered one of the safest second-generation antihistamines regarding cardiac effects. Unlike terfenadine and astemizole (withdrawn from market), cetirizine has minimal potassium channel (IKr) blockade and does not prolong QT interval 8. However, recent pharmacovigilance data identified a signal for pericarditis with cetirizine (though rare) 9, warranting awareness but not contraindication.

Bleeding Risk with Apixaban

The primary concern with apixaban is pharmacodynamic bleeding risk when combined with antiplatelet agents, NSAIDs, or other anticoagulants 1, 10, 11. Cetirizine does not affect hemostasis and does not increase bleeding risk.

Common Pitfalls to Avoid

  • Sedation: Cetirizine can cause drowsiness, which may be additive with carvedilol's fatigue side effects. This is a pharmacodynamic effect, not a drug interaction, but patients should be counseled about potential increased sedation 12.
  • Renal impairment: If you have significant renal dysfunction (CrCl <30 mL/min), cetirizine dose should be reduced to 5 mg daily 12, but this doesn't change the interaction profile with your other medications.

Bottom Line

You can safely take Zyrtec with all four of your medications. No dose adjustments are needed for any of these drugs based on cetirizine use. The only practical consideration is potential additive sedation, which can be managed by taking cetirizine at bedtime if drowsiness occurs.

References

Research

Cardiovascular safety of second-generation antihistamines.

American journal of rhinology, 1999

Research

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Hematology. American Society of Hematology. Education Program, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.